Radius Health, Inc. Files Registration Statement for Proposed Public Offering
(firmenpresse) - CAMBRIDGE, MA -- (Marketwire) -- 02/07/12 -- Radius Health, Inc., a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions, today announced that it has filed a registration statement with the Securities and Exchange Commission relating to a proposed public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. All the proposed shares in the offering will be sold by Radius Health, Inc.
UBS Investment Bank and Leerink Swann LLC are acting as joint book-running managers and underwriters for the proposed offering. Cowen and Company, LLC and Rodman & Renshaw, LLC are serving as co-managers for the proposed offering.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time that the registration statement becomes effective.
When available, copies of the preliminary prospectus relating to the proposed offering may be obtained by contacting UBS Investment Bank, Attention: Prospectus Department, 299 Park Avenue, New York, NY 10171, (888) 827-7275, or Leerink Swann LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, (800) 808-7525, ext. 4814.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 07.02.2012 - 05:00 Uhr
Sprache: Deutsch
News-ID 1080082
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
CAMBRIDGE, MA
Phone:
Kategorie:
Venture Capital
Anmerkungen:
Diese Pressemitteilung wurde bisher 79 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Radius Health, Inc. Files Registration Statement for Proposed Public Offering
"
steht unter der journalistisch-redaktionellen Verantwortung von
Radius Health, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
